Search for: "MERCK SHARP & DOHME" Results 41 - 60 of 238
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jan 2019, 2:05 pm by Oyez Project
The court heard argument this week in: Merck Sharp & Dohme Corp. v. [read post]
28 Nov 2011, 6:31 am
The Department of Justice recently announced a resolution with pharmaceutical giant Merck, Sharp & Dohme ("Merck") to pay $950 million to settle criminal and civil claims for its illegal promotion and marketing of its painkiller drug, Vioxx. [read post]
6 Jan 2019, 9:00 am by Andrew Hamm
On Monday, the justices hear oral argument in Merck Sharp & Dohme Corp. v. [read post]
23 Nov 2011, 7:35 pm by eithurburn@getnicklaw.com
Pharmaceutical Company Merck Sharp & Dohme to Pay Nearly One Billion Dollars Over Promotion of Vioxx" [read post]
22 Nov 2015, 9:59 pm by Patent Docs
Merck Sharp & Dohme Corp. v. [read post]
17 Oct 2021, 9:24 pm by Patent Docs
Ltd v Commissioner of Patents [2021] FCA 643, and Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2021] FCA 947. [read post]
4 Mar 2023, 8:45 pm by Patent Docs
Irving of Finnegan Henderson Farabow Garrett & Dunner, Sarah Hooson of Merck Sharp & Dohme, Krista Kostiew of Unilever, and Xiaoguang Michelle Gao of Eli Lilly and Company will guide patent counsel on recent trends and developments in patent practice; examine the Supreme Court, Federal Circuit, and PTAB cases from the past year; and discuss some of the key developments and strategies.... [read post]
5 Aug 2013, 9:59 pm by Patent Docs
The UK High Court recently gave its judgment in the case of Merck, Sharp & Dohme Corp. and Bristol-Myers Squibb Pharmaceuticals Ltd (collectively referred to in the judgement as BMS) v Teva Pharma B.V. and Teva UK Ltd (Teva) (decision). [read post]
11 Feb 2023, 7:17 pm by Patent Docs
MacAlpine of Finnegan Henderson Farabow Garrett & Dunner, and Sarah Hooson of Merck Sharp & Dohme will guide patent counsel on recent Orange Book developments; discuss Orange Book listing practices and the implications for patent prosecution, listing, and litigation; and examine contemporary thought about Form 3542 and pitfalls to avoid.... [read post]
24 Nov 2020, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit has taken the occasion, in appeals from the Patent Trial and Appeal Board as well as district courts, to remand judgments whenever the Court believes that the record below is devoid of sufficient detail to properly assess the correctness of the decisions made below (see "Merck Sharp & Dohme Corp. v. [read post]
25 Jun 2021, 4:15 am by Logan Murr
., Bristol-Myers Squibb Company, Corning Incorporated, and Merck Sharp & Dohme Corp. filed amicus briefs. [read post]
10 Apr 2011, 1:43 am
In my article "Divided by a common language: US and UK patent law" which was published in Science, People & Politics (April to June 2011) I noted that one of the differences between US and UK patent law was that 35 USC 102 (b) of the US act permits an application for a US patent even where the invention has been described in a publication or application for a foreign patent that has been made in [read post]